RelB EMSA status and characteristics of the 66 de novo DLBCL patients
Patient no. . | COO . | Age, y . | Sex . | IPI . | RelB EMSA status . |
---|---|---|---|---|---|
1 | GCB | 43 | Male | 0 | NEG |
2 | ABC | 55 | Female | 1 | POS |
3 | ABC | 66 | Male | 4 | POS |
4 | ABC | 61 | Female | 3 | POS |
5 | ABC | 65 | Female | 5 | POS |
6 | GCB | 52 | Male | 2 | POS |
7 | ABC | 76 | Female | 4 | POS |
8 | ABC | 61 | Male | 3 | POS |
9 | ABC | 66 | Male | 3 | POS |
10 | ABC | 83 | Female | 4 | NEG |
11 | ABC | 43 | Female | 4 | NEG |
12 | ABC | 58 | Male | 3 | POS |
13 | ABC | 66 | Female | 3 | NEG |
14 | ABC | 68 | Female | 4 | POS |
15 | GCB | 60 | Male | 4 | POS |
16 | ABC | 76 | Female | 3 | POS |
17 | ABC | 76 | Female | 5 | POS |
18 | ABC | 87 | Male | 5 | POS |
19 | ABC | 56 | Male | 1 | NEG |
20 | GCB | 70 | Male | 2 | POS |
21 | ABC | 66 | Male | 3 | NEG |
22 | GCB | 49 | Female | 3 | POS |
23 | ABC | 26 | Female | 1 | POS |
24 | ABC | 38 | Male | 1 | POS |
25 | ABC | 78 | Female | 4 | NEG |
26 | GCB | 46 | Female | 0 | NEG |
27 | GCB | 38 | Male | 0 | POS |
28 | GCB | 53 | Female | 3 | NEG |
29 | ABC | 54 | Female | 0 | NEG |
30 | ABC | 50 | Female | 2 | NEG |
31 | ABC | 72 | Male | 4 | NEG |
32 | ABC | 76 | Female | 2 | POS |
33 | ABC | 53 | Female | 1 | POS |
34 | GCB | 20 | Male | 1 | POS |
35 | GCB | 61 | Male | 1 | POS |
36 | GCB | 72 | Male | 2 | NEG |
37 | ABC | 55 | Female | 1 | NEG |
38 | ABC | 55 | Male | 3 | NEG |
39 | ABC | 67 | Male | 2 | POS |
40 | ABC | 61 | Female | 5 | POS |
41 | ABC | 80 | Male | 5 | POS |
42 | ABC | 65 | Female | 4 | POS |
43 | GCB | 24 | Female | 0 | POS |
44 | GCB | 26 | Male | 2 | NEG |
45 | GCB | 39 | Female | 4 | POS |
46 | ABC | 75 | Male | 5 | POS |
47 | ABC | 63 | Female | 5 | POS |
48 | ABC | 24 | Male | 1 | POS |
49 | GCB | 48 | Female | 4 | POS |
50 | GCB | 68 | Female | 3 | NEG |
51 | ABC | 81 | Female | 5 | POS |
52 | ABC | 81 | Male | 3 | NEG |
53 | ABC | 52 | Female | 1 | POS |
54 | ABC | 59 | Female | 1 | POS |
55 | ABC | 52 | Female | 1 | NEG |
56 | GCB | 44 | Female | 3 | POS |
57 | GCB | 77 | Female | 3 | POS |
58 | ABC | 58 | Female | 0 | POS |
59 | GCB | 51 | Female | 3 | POS |
60 | GCB | 52 | Female | 2 | NEG |
61 | GCB | 62 | Male | 3 | POS |
62 | ABC | 83 | Male | 4 | POS |
63 | GCB | 50 | Male | 2 | POS |
64 | GCB | 61 | Male | 1 | NEG |
65 | GCB | 53 | Male | 1 | NEG |
66 | GCB | 32 | Female | 1 | POS |
Patient no. . | COO . | Age, y . | Sex . | IPI . | RelB EMSA status . |
---|---|---|---|---|---|
1 | GCB | 43 | Male | 0 | NEG |
2 | ABC | 55 | Female | 1 | POS |
3 | ABC | 66 | Male | 4 | POS |
4 | ABC | 61 | Female | 3 | POS |
5 | ABC | 65 | Female | 5 | POS |
6 | GCB | 52 | Male | 2 | POS |
7 | ABC | 76 | Female | 4 | POS |
8 | ABC | 61 | Male | 3 | POS |
9 | ABC | 66 | Male | 3 | POS |
10 | ABC | 83 | Female | 4 | NEG |
11 | ABC | 43 | Female | 4 | NEG |
12 | ABC | 58 | Male | 3 | POS |
13 | ABC | 66 | Female | 3 | NEG |
14 | ABC | 68 | Female | 4 | POS |
15 | GCB | 60 | Male | 4 | POS |
16 | ABC | 76 | Female | 3 | POS |
17 | ABC | 76 | Female | 5 | POS |
18 | ABC | 87 | Male | 5 | POS |
19 | ABC | 56 | Male | 1 | NEG |
20 | GCB | 70 | Male | 2 | POS |
21 | ABC | 66 | Male | 3 | NEG |
22 | GCB | 49 | Female | 3 | POS |
23 | ABC | 26 | Female | 1 | POS |
24 | ABC | 38 | Male | 1 | POS |
25 | ABC | 78 | Female | 4 | NEG |
26 | GCB | 46 | Female | 0 | NEG |
27 | GCB | 38 | Male | 0 | POS |
28 | GCB | 53 | Female | 3 | NEG |
29 | ABC | 54 | Female | 0 | NEG |
30 | ABC | 50 | Female | 2 | NEG |
31 | ABC | 72 | Male | 4 | NEG |
32 | ABC | 76 | Female | 2 | POS |
33 | ABC | 53 | Female | 1 | POS |
34 | GCB | 20 | Male | 1 | POS |
35 | GCB | 61 | Male | 1 | POS |
36 | GCB | 72 | Male | 2 | NEG |
37 | ABC | 55 | Female | 1 | NEG |
38 | ABC | 55 | Male | 3 | NEG |
39 | ABC | 67 | Male | 2 | POS |
40 | ABC | 61 | Female | 5 | POS |
41 | ABC | 80 | Male | 5 | POS |
42 | ABC | 65 | Female | 4 | POS |
43 | GCB | 24 | Female | 0 | POS |
44 | GCB | 26 | Male | 2 | NEG |
45 | GCB | 39 | Female | 4 | POS |
46 | ABC | 75 | Male | 5 | POS |
47 | ABC | 63 | Female | 5 | POS |
48 | ABC | 24 | Male | 1 | POS |
49 | GCB | 48 | Female | 4 | POS |
50 | GCB | 68 | Female | 3 | NEG |
51 | ABC | 81 | Female | 5 | POS |
52 | ABC | 81 | Male | 3 | NEG |
53 | ABC | 52 | Female | 1 | POS |
54 | ABC | 59 | Female | 1 | POS |
55 | ABC | 52 | Female | 1 | NEG |
56 | GCB | 44 | Female | 3 | POS |
57 | GCB | 77 | Female | 3 | POS |
58 | ABC | 58 | Female | 0 | POS |
59 | GCB | 51 | Female | 3 | POS |
60 | GCB | 52 | Female | 2 | NEG |
61 | GCB | 62 | Male | 3 | POS |
62 | ABC | 83 | Male | 4 | POS |
63 | GCB | 50 | Male | 2 | POS |
64 | GCB | 61 | Male | 1 | NEG |
65 | GCB | 53 | Male | 1 | NEG |
66 | GCB | 32 | Female | 1 | POS |
PI, International Prognostic Index.